Press release
Outcast or Evolutionary Leap? Sci-Fi Thriller Gene Zero Explores a Future Where Genetic Failure Sparks Hope
In the not-so-distant future, society thrives on genetic perfection through the Symbiote Bonding Program-a government initiative that fuses teenagers with genetically engineered organisms to unlock enhanced abilities. But for 15-year-old Brian Park, the ceremony ends in humiliation and despair. His bond fails, branding him a "zero"-a social outcast without enhancement, stripped of future opportunities and doomed to live in shame.
However, Brian soon learns that failure is a lie. He begins to manifest astonishing powers: telekinesis, superhuman speed, and a mysterious internal voice-a rogue symbiote with its own agenda. What begins as confusion soon turns into a life-threatening revelation. Brian hasn't failed; he's become something different. Something dangerous. Something uncontrollable.
As Brian navigates betrayal, government secrets, and violent conflict, he realizes his "defect" could be a new step in human evolution-or a trigger for its end. With the clock ticking and factions closing in, Brian must decide whether to embrace the monster inside him or rewrite the rules of survival for everyone.
"Gene Zero was born out of my fascination with biotechnology, control, and how we assign value to people," said Moshe Lewis, author and practicing physician. "At its core, this book is about transformation and courage. Brian's journey mirrors the internal battle we all face: Who am I, and what do I do when the world tells me I'm not enough?"
Combining thrilling action sequences with emotional depth and scientific intrigue, Gene Zero delivers a high-concept adventure that resonates with readers of Divergent, Ender's Game, and Renegades. Lewis creates a compelling dystopian world layered with ethical complexity, futuristic tech, and unforgettable characters, each caught in the web of a government obsessed with control.
The book's originality lies in its deep dive into biopunk-a subgenre of science fiction focusing on genetic manipulation and synthetic biology. Lewis presents a society where artificial enhancement is a rite of passage, but questions who gets to define perfection and what happens when nature defies the system.
Early readers have praised the novel for its unique world-building and emotional impact. "Gene Zero is fast-paced, cinematic, and thought-provoking. I couldn't put it down," said one reviewer. "Brian Park is the kind of hero we need-flawed, brave, and relentlessly human."
About the Author:
Moshe Lewis is not just a storyteller but also a physician with a passion for exploring how science and society intersect. His background in medicine adds a layer of realism to the genetic science depicted in Gene Zero. This is his debut fiction novel, marking the beginning of what promises to be an exciting new voice in speculative fiction.
Gene Zero is now available on Amazon in eBook and paperback formats. Sci-fi fans, book reviewers, educators, and libraries are encouraged to explore this powerful debut.
Genre: YA Science Fiction / Biopunk Thriller
ISBN: B0DXRT38DJ
Publisher: Juniper Vivaldi Publishing
Release Date: Now Available
Media Contact
Company Name: Juniper Vivaldi Publishing
Contact Person: Melanie Thompson
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=outcast-or-evolutionary-leap-scifi-thriller-gene-zero-explores-a-future-where-genetic-failure-sparks-hope]
Phone: +1 888 280-4331
Address:4900 Lacross Rd.
City: North Charleston
State: South Carolina
Country: United States
Website: https://www.amazon.com/Gene-Zero-Biopunk-Moshe-Lewis-ebook/dp/B0DXRT38DJ
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Outcast or Evolutionary Leap? Sci-Fi Thriller Gene Zero Explores a Future Where Genetic Failure Sparks Hope here
News-ID: 4029300 • Views: …
More Releases from ABNewswire
Award-Winning Artist Anna Rose Bain Reveals Her Secret Weapon: Artefex Panels
Signature Portrait Society member Anna Rose Bain reveals why she has transitioned her professional portfolio to Artefex's archival aluminum composite (ACM) panels to ensure her "visual journals" survive for generations. Artefex helps artists eliminate the risk of warping and rotting common in traditional canvases.
ARVADA, CO - For professional artists, the greatest threat to a creative legacy isn't a lack of vision, but the physical degradation of the artwork itself. Today,…
Leading Law Group Targets Legal Equity for Women Facing Divorce and Custody Batt …
Women's Divorce & Family Law Group Helps Divorcing Individuals Overcome Uncertainty, Protect Their Assets, and Secure the Future of Their Families
CHICAGO, Illinois - As divorce rates in Illinois continue to reflect the growing complexities of modern family life, Women's Family Lawyers has announced an expansion of its dedicated legal services for individuals seeking professional guidance through the divorce process. Every Chicago Divorce Lawyer [https://www.womensfamilylawyers.com/family-law/chicago-divorce-lawyers/] on our team is committed to…
Inside Post-Realm FW26: A Cross-Cultural Vision at New York Fashion Week
The Post-Realm FW26 New York Fashion Show, presented by NotYetArt Inc., concluded on February 15, 2026, at 17 Saratoga Ave in New York as part of the CFDA listing.
Centered on the theme "Post-Realm," the showcase explored identity, structure, and transformation within contemporary fashion. The concept examined the space between tradition and futurism, East and West, and fashion and interdisciplinary art practices - positioning the runway as a platform for cross-cultural…
Sydney Business School Alumni Launch Australia's First AI-Driven Wholesale Inves …
Sydney Business School alumni Adnan Tanveer and Adam Newman are launching Investing Platform, Australia's first AI-driven wholesale investment marketplace, in Q1 2026. The platform addresses a key problem: qualified investors currently face seven months and thousands in fees to access a single alternative investment. The founders combine 20+ years of experience with hands-on AI development.
SYDNEY, AUSTRALIA - Investing Platform aims to cut months of friction from wholesale investor access.
Adnan Tanveer…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
